truncated tissue factor
Recombinant proteinexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 8, 2017 (NCT02902237)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor IIISupplementation
F3 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- truncated tissue factor
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02902237 | Phase 1 | May 8, 2017 | Deutsche Krebshilfe e.V., University of Munster |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Deutsche Krebshilfe e.V. | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Munster | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1